CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $542 | +36.2% | 19,881 | +11.2% | 0.00% | +50.0% |
| Q2 2023 | $398 | +2.8% | 17,881 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $387 | +6.6% | 17,881 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $363 | -99.9% | 17,881 | -22.1% | 0.00% | -50.0% |
| Q3 2022 | $589,000 | +7.9% | 22,960 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $546,000 | +3.8% | 22,960 | -1.7% | 0.00% | +33.3% |
| Q1 2022 | $526,000 | -4.4% | 23,360 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $550,000 | +0.7% | 27,760 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $546,000 | -10.6% | 27,760 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $611,000 | +47.9% | 27,760 | +59.9% | 0.00% | +50.0% |
| Q1 2021 | $413,000 | -9.0% | 17,360 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $454,000 | +50.3% | 17,360 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $302,000 | -48.3% | 17,360 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $584,000 | – | 34,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |